Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 09 September, 2008 and appeared in  Issue 433

Novel Short-Term Weight-Loss Approach Works Long-Term

A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term. The focus was on weight loss and not as much on glucose control.
Advertisement
In addition, participants were able to keep their blood glucose in control on fewer medications and had significant reductions in their total cholesterol, triglycerides, LDL or "bad" cholesterol and C-reactive protein - a measure of inflammation linked to heart attack risk.

The study, showed patients with type 2 diabetes enrolled in Joslin's Weight Achievement and Intensive Treatment program (Why WAIT) lost on average 23.5 pounds or 9.8 percent of their initial body weight during the 12-week program.
At the conclusion of one-year of follow-up, the average weight loss was 18.2 pounds or 7.6 percent of initial body weight. Participants also saw an average of 3.7 inch reductions in waist circumference and a significant reduction in body fat percentage while keeping their lean body mass up.

"Our study shows that the Why WAIT program's novel combination of diet changes, an exercise plan and medication change, in association with behavioral support and education, works long-term when patients are back on their own in the real world," said Osama Hamdy, M.D., Ph.D., medical director of the Obesity Clinical Program at Joslin and the study's lead investigator.

Why WAIT is a 12-week multidisciplinary diabetes weight management program designed for clinical practice. The program, which is mostly covered by insurance, includes a change in diabetes medications to enhance weight reduction by eliminating or reducing medications that can cause weight gain, structured dietary intervention with about 40 percent of daily calories from carbohydrates and 30 percent from protein, high fiber, no trans fats and reduced saturated fats, meal replacement drinks that follow the same dietary composition, an exercise program with an emphasis on strength training, and weekly educational and behavioral support sessions.

"For the last few years, we have been looking for a new target to treat type 2 diabetes," Hamdy said. "Lowering blood glucose levels alone doesn't seem to help to prevent the cardiovascular complications associated with type 2 diabetes. This is why we created the Why WAIT weight-management program."

Reductions in blood pressure, cholesterol levels and inflammation markers indicate that the Why WAIT approach may eventually reduce the risk of cardiac and cerebral events, which are the main causes of death in individuals with diabetes, Hamdy added.

In addition to weight-loss and reductions in cardiovascular risk factors, Why WAIT participants also saw significant decreases in the amounts of diabetes medications they were taking, as well as an associated reduction in medication costs. Patients saved, on average, $561 per year on their diabetes medications alone and the study projected an annual decrease of total health care costs of about $1,619 per patient.

"Many participants were able to stop their diabetes medications altogether," Hamdy said.

According to the paper, 21 percent of participants on short-acting insulin were able to stop it completely by the end of the program. Remaining patients on insulin therapy were able to reduce their daily dose of long-acting insulin by an average of 55 percent and their daily dose of short-acting insulin dropped by 54 percent. Almost two-thirds of patients on sulfonylureas were able to stop them while remaining participants reduced their doses by between 35 and 41 percent.

"In treating type 2 diabetes, we have been glucose-focused for several decades. It may be the time to switch our efforts to target body weight as the core of the problem," he said. "The Why WAIT program clearly shows that weight-based diabetes management is a future potential alternative model to glucose-based management. It resulted in a reduction in medication use and cost, and more people were on target for diabetes control with improved quality of life."

August issue of Obesity Management
======================================

DID YOU KNOW: 
Heart Rate of More Than 70 Beats Per Minute Increases Risk of Heart Failure: The finding that heart rate, specifically a heart rate more than 70 beats per minute, increased the risk of cardiac events in heart failure patients was the top take-home message for the Dutch cardiologist who chaired the European Society of Cardiology program committee.

======================================

Advertisement
Do you, or someone that you know, need guidance and support to deal with the challenges of weight, food and diabetes?
Fit4D offers diabetes coaching, delivered virtually through group class and 1:1 formats, supporting your individualized needs as a person living with diabetes, with an emphasis on nutrition, exercise, fitness, motivation, weight loss, blood sugar management and guidance.  In addition to providing you with a virtual support system,  Fit4D's team of nurses, exercise physiologists, registered dietitians and personal trainers works with your existing doctors and medical providers to develop a customized, medically safe strategy of weight loss, diet and exercise that meets your unique personal needs and health care requirements.
Class and 1:1 diabetes coaching membership information is available at: www.fit4d.com or by calling 866-411-0254.  Mention Diabetes in Control and receive 10% off of upcoming classes or a 1:1 Personalized Coaching Membership!

http://www.diabetesincontrol.com/ads/fit4d/index.php
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 09 September, 2008 and appeared in  Issue 433

Past five issues: Diabetes Clinical Mastery Series Issue 69 | Issue 611 | Issue 610 | Diabetes Clinical Mastery Series Issue 68 | Issue 609 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Do your type 2 patients not on insulin count their carbs and report back to you?

Navigate Diabetes In Control



Search Articles On Diabetes In Control